Pharmacotherapy of Duchenne Muscular Dystrophy (DMD)
Duchenne Muscular Dystrophy (DMD) is a severe, progressive neuromuscular disorder caused by mutations in the DMD gene, leading to the absence of functional dystrophin protein.
Poornachandran, Deepti Nirja
core
Enfermedades genéticas: distrofia muscular de Duchenne
María GARCÍA MORO +2 more
doaj
Functional electrical stimulation for major depressive disorder: Protocol for a pilot randomized controlled trial. [PDF]
Gholamali Nezhad F +12 more
europepmc +1 more source
Genetic Analysis and Reproductive Intervention in a Duchenne Muscular Dystrophy Family With Cryptic Complex Chromosomal Rearrangement Identified by Structural Variation Sequencing. [PDF]
Qin S +6 more
europepmc +1 more source
Dysphagia in Older Adults as a Geriatric Syndrome: From Disease-Based Diagnosis to Mechanism-Based Assessment. [PDF]
Takahata H.
europepmc +1 more source
Characterization of Dystrophin-Related Syndromes: Carriers, DMD, and BMD. [PDF]
Chabbi N +4 more
europepmc +1 more source
Echocardiography in duchenne muscular dystrophy: a call for consistency and standardisation of reporting. [PDF]
Williams L +20 more
europepmc +1 more source
Current and prospective treatment of Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a serious condition of genetic origin that is passed down in the X-linked manner and that mainly afflicts boys. It is the result of a steady muscle tissue degeneration caused by mutations in the dystrophin gene on the
Rodriguez, Isaac
core
Positive allosteric modulator of SERCA pump NDC-1171 attenuates cardiac functional decline in mouse model of Duchenne muscular dystrophy. [PDF]
Narra N +6 more
europepmc +1 more source
Duchenne muscular dystrophy (DMD) is a progressive and severe X-linked recessive disorder characterized by progressive muscle weakness due to degeneration of muscle fibers resulting in a shortened life span.
Ninsiima , Karen Tukahirwa Jessica
core

